Mahler Vera, Junker Ann-Christine
Paul-Ehrlich-Institut, Paul-Ehrlich-Straße 51-59, 63225 Langen, Germany.
Allergo J Int. 2022;31(5):123-136. doi: 10.1007/s40629-022-00215-8. Epub 2022 Jun 14.
Anaphylaxis in connection with the administration of vaccines occurs only very rarely. Triggers of immunoglobulin IgE-mediated and non-IgE-mediated anaphylaxis-in addition to the active ingredient itself-may be excipients contained in the vaccine due to their special properties. Some of the excipients in medicinal products are the same compounds used as additives in food. Furthermore, residues from the manufacturing process (e.g., chicken egg white, casein, antibiotics, formaldehyde) or contaminants (e.g., from the primary packaging material) may be potential triggers of anaphylaxis in vaccines. This review article provides an overview of ingredients in vaccines that pose an allergenic risk potential. The components of COVID-19 vaccines approved and marketed in Germany are discussed with regard to their potential for triggering anaphylaxis and possible pathophysiological mechanisms involved.
与疫苗接种相关的过敏反应极为罕见。除活性成分本身外,免疫球蛋白IgE介导和非IgE介导的过敏反应的触发因素可能是疫苗中所含的辅料,因其特殊性质所致。药品中的一些辅料与食品添加剂中的化合物相同。此外,生产过程中的残留物(如鸡蛋白、酪蛋白、抗生素、甲醛)或污染物(如来自一级包装材料)可能是疫苗过敏反应的潜在触发因素。这篇综述文章概述了疫苗中具有潜在过敏风险的成分。讨论了在德国批准上市的新冠疫苗的成分引发过敏反应的可能性以及可能涉及的病理生理机制。